Lexicon Pharmaceuticals LXRX Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's other working capital?
- Lexicon Pharmaceuticals (LXRX) reported other working capital of $581K in Q1 2026.
- How has Lexicon Pharmaceuticals's other working capital changed year-over-year?
- Lexicon Pharmaceuticals's other working capital decreased by 62.3% year-over-year, from $1.54M to $581K.
- What is the long-term trend for Lexicon Pharmaceuticals's other working capital?
- Over 2 years (2023 to 2025), Lexicon Pharmaceuticals's other working capital has grown at a 7.3% compound annual growth rate (CAGR), from -$1.51M to $1.74M.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.